Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting - Contacts and Locations

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE)

This study is currently recruiting participants.

Study NCT00661206. Last updated on November 3, 2008. Information provided by Deutsches Herzzentrum Muenchen

Please refer to this study by its ClinicalTrials.gov identifier: NCT00661206

Contacts

Locations


Germany
	1st Medizinische Klinik, Klinikum rechts der Isar	Recruiting
	Munich, Germany, 81675
	Contact: Josef Dirschinger, MD 49-89-4041-2947 dirschinger@med1.med.tum.de
	Principal Investigator: Josef Dirschinger
	Deutsches Herzzentrum München	Recruiting
	Munich, Germany, 81541
	Contact: Julinda Mehilli, MD +49-89-1218 ext 4582 mehilli@dhm.mhn.de
	Contact: Stefanie Schulz, MD +49-89-1218 ext 1521 schulzs@dhm.mhn.de
	Principal Investigator: Julinda Mehilli, MD

Netherlands
	St. Antonius Hospital Department of Cardiology	Not yet recruiting
	Nieuwegein, Netherlands, 3435
	Contact: Jurriёn M ten Berg, MD jurtenberg@wxs.nl
	Principal Investigator: Jurriёn M ten Berg, MD

Sponsors and Collaborators

Deutsches Herzzentrum Muenchen

Investigators


Study Chair:	Adnan Kastrati, MD	Deutsches Herzzentrum Muenchen

Principal Investigator:	Julinda Mehilli, MD	Deutsches Herzzentrum Muenchen

Principal Investigator:	Jurriёn M ten Berg, MD	Department of Cardiology; St. Antonius Hospital; 3435 CM Nieuwegein; The Netherlands